Literature DB >> 10702166

Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease.

M P Engelen1, A M Schols, J D Does, E F Wouters.   

Abstract

BACKGROUND: Skeletal muscle weakness is a prominent problem in many patients with chronic obstructive pulmonary disease (COPD).
OBJECTIVE: The aim of the study was to determine the relation between skeletal muscle function, body composition, and lung function in COPD (emphysema and chronic bronchitis) patients and healthy volunteers.
DESIGN: In 50 patients with chronic bronchitis, 49 patients with emphysema, and 28 healthy volunteers, skeletal muscle function was assessed by handgrip and linear isokinetic dynamometry. Whole-body and subregional fat-free mass (FFM) were assessed by dual-energy X-ray absorptiometry.
RESULTS: Whole-body and extremity FFM were significantly lower in patients with emphysema (P < 0.001) and chronic bronchitis (P < 0.05) than in healthy volunteers, but trunk FFM was significantly lower only in patients with emphysema (P < 0.001). Extremity FFM was not significantly different between the COPD subtype groups, despite significantly lower values for whole-body and trunk FFM (P < 0.05) in patients with emphysema. Absolute skeletal muscle function (P < 0. 001) and muscle function per kilogram of whole-body FFM were significantly lower in both COPD subtype groups than in healthy volunteers (P < 0.05), but no significant difference was found between patients with chronic bronchitis and those with emphysema. Muscle function per kilogram of extremity FFM was not significantly different between the 3 groups and was not associated with forced expiratory volume in 1 s.
CONCLUSION: Skeletal muscle weakness is associated with wasting of extremity FFM in COPD patients, independent of airflow obstruction and COPD subtype.

Entities:  

Mesh:

Year:  2000        PMID: 10702166     DOI: 10.1093/ajcn/71.3.733

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  50 in total

Review 1.  Respiratory muscle function and free radicals: from cell to COPD.

Authors:  L M Heunks; P N Dekhuijzen
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease.

Authors:  Anja Walter-Kroker; Axel Kroker; Muriel Mattiucci-Guehlke; Thomas Glaab
Journal:  Nutr J       Date:  2011-04-21       Impact factor: 3.271

Review 3.  Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Authors:  Karin J C Sanders; Samuel Y Ash; George R Washko; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Appl Physiol (1985)       Date:  2017-07-27

4.  Altered tissue distribution in adults with cystic fibrosis.

Authors:  C E Bolton; A A Ionescu; W D Evans; R J Pettit; D J Shale
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

5.  Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients.

Authors:  Seokkee Lee; Hyo Chae Paik; Seok Jin Haam; Chang Young Lee; Kyung Sik Nam; Hee Suk Jung; Young Woo Do; Jee Won Shu; Jin Gu Lee
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle.

Authors:  Vladimir T Basic; Elsa Tadele; Ali Ateia Elmabsout; Hongwei Yao; Irfan Rahman; Allan Sirsjö; Samy M Abdel-Halim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

7.  Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Authors:  Mark D Eisner; Carlos Iribarren; Edward H Yelin; Stephen Sidney; Patricia P Katz; Lynn Ackerson; Phenius Lathon; Irina Tolstykh; Theodore Omachi; Nancy Byl; Paul D Blanc
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

Review 8.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

9.  Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial.

Authors:  Carel R van Wetering; Floortje E van Nooten; Stijn J M Mol; Martine Hoogendoorn; Maureen P M H Rutten-Van Mölken; Annemie M Schols
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.